David Weill
Direktor/Vorstandsmitglied bei TRANSMEDICS GROUP, INC.
Vermögen: 957 831 $ am 30.04.2024
Aktive Positionen von David Weill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRANSMEDICS GROUP, INC. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
| Independent Dir/Board Member | 01.01.2019 | - | |
| Weill Consulting Group | Corporate Officer/Principal | 01.01.2016 | - |
TransMedics, Inc.
 TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von David Weill
Ehemalige bekannte Positionen von David Weill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Stanford University Medical Center | Corporate Officer/Principal | 01.01.2005 | 01.01.2016 |
| Stanford Center For Advanced Lung Diseases | Direktor/Vorstandsmitglied | - | - |
Ausbildung von David Weill
| Tulane University (Louisiana) | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRANSMEDICS GROUP, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Health Technology |
| Weill Consulting Group | |
| Stanford Center For Advanced Lung Diseases | |
| Stanford University Medical Center |
- Börse
- Insiders
- David Weill
- Erfahrung